Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Effect of short-term infusion of sodium nitroprusside on mortality rate in acute myocardial infarction complicated by left ventricular failure: results of a Veterans Administration cooperative study.

Cohn JN, Franciosa JA, Francis GS, Archibald D, Tristani F, Fletcher R, Montero A, Cintron G, Clarke J, Hager D, Saunders R, Cobb F, Smith R, Loeb H, Settle H.

N Engl J Med. 1982 May 13;306(19):1129-35.

PMID:
7040956
2.

Effect of sodium nitroprusside on mortality in acute myocardial infarction.

Durrer JD, Lie KI, van Capelle FJ, Durrer D.

N Engl J Med. 1982 May 13;306(19):1121-8.

PMID:
7040955
5.

Effects of combined dopamine and nitroprusside therapy in patients with severe pump failure and hypotension complicating acute myocardial infarction.

Keung EC, Ribner HS, Schwartz W, Sonnenblick EH, LeJemtel TH.

J Cardiovasc Pharmacol. 1980;2(2):113-9.

PMID:
6171679
7.

Beneficial effects of timolol on infarct size and late ventricular tachycardia in patients with acute myocardial infarction.

Roqué F, Amuchastegui LM, Lopez Morillos MA, Mon GA, Girotti AL, Drajer S, Fortunato M, Moreyra E, Tuero P, Solchaga JC, et al.

Circulation. 1987 Sep;76(3):610-7.

PMID:
3304706
8.

Long-term mortality in patients with myocardial infarction: impact of early treatment with captopril for 4 weeks.

Liu L; Chinese Cardiac Study (CCS-I) Collaborative Group.

Chin Med J (Engl). 2001 Feb;114(2):115-8.

PMID:
11780187
9.

Haemodynamic effects of intravenous sotalol in acute myocardial infarction.

Aström M, Edhag O, Nyquist O, Vallin H.

Eur Heart J. 1986 Nov;7(11):931-6.

PMID:
3539617
10.
11.

Effect of propranolol on myocardial-infarct size in a randomized blinded multicenter trial.

Roberts R, Croft C, Gold HK, Hartwell TD, Jaffe AS, Muller JE, Mullin SM, Parker C, Passamani ER, Poole WK, et al.

N Engl J Med. 1984 Jul 26;311(4):218-25.

PMID:
6377070
12.
13.

[8-hour hemodynamic study of 2 sustained-release nitrate derivatives. Comparative double-blind study against placebo].

Dubourg O, Guéret P, Ferrier A, Léger P, Farcot JC, Rigaud M, Beaumont D, Bardet J, Bourdarias JP.

Arch Mal Coeur Vaiss. 1983 Feb;76(2):211-9. French.

PMID:
6407429
14.

Randomized controlled trial of vasodilator therapy after myocardial infarction.

Hockings BE, Cope GD, Clarke GM, Taylor RR.

Am J Cardiol. 1981 Aug;48(2):345-52.

PMID:
7023223
15.

Nifedipine in acute myocardial infarction: an assessment of left ventricular function, infarct size, and infarct expansion. A double blind, randomised, placebo controlled trial.

Gottlieb SO, Becker LC, Weiss JL, Shapiro EP, Chandra NC, Flaherty JT, Gottlieb SH, Ouyang P, Mellits ED, Townsend SN, et al.

Br Heart J. 1988 Apr;59(4):411-8.

16.

Epoprostenol sodium (prostacyclin) infusion in acute myocardial infarction.

Kiernan FJ, Kluger J, Regnier JC, Rutkowski M, Fieldman A.

Br Heart J. 1986 Nov;56(5):428-32.

17.

Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial.

Amit G, Cafri C, Yaroslavtsev S, Fuchs S, Paltiel O, Abu-Ful A, Weinstein JM, Wolak A, Ilia R, Zahger D.

Am Heart J. 2006 Nov;152(5):887.e9-14.

PMID:
17070151
18.

A double blind placebo controlled study of early and late administration of recombinant tissue plasminogen activator in acute myocardial infarction.

McNeill AJ, Cunningham SR, Flannery DJ, Dalzell GW, Wilson CM, Campbell NP, Khan MM, Patterson GC, Webb SW, Adgey AA.

Br Heart J. 1989 Apr;61(4):316-21.

19.

Supplemental Content

Support Center